Implications of Price Erosion of Docetaxel After Loss of Exclusivity on Cost-Effectivess
Nov 1, 2016, 00:00 AM
10.1016/j.jval.2016.08.268
https://www.valueinhealthjournal.com/article/S1098-3015(16)30848-8/fulltext
Section Title :
Disease-Specific Studies
Section Order :
2729
First Page :
A887
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)30848-8&doi=10.1016/j.jval.2016.08.268